UroToday.com Prostate cancer has been the most common visceral malignant neoplasm in U.S. men since 1984, now accounting for one third of all such cancers. Androgensuppressing strategies have become the mainstay for the management of advanced prostate cancer. Surgical castration is still considered the gold standard for androgen deprivation therapy (ADT) against which all [...]

UroToday.com The diagnosis of localised prostate cancer is increasing due to increased awareness and increased testing. There are a number of treatment options available to many of these men, including surgery, radiotherapy, active surveillance and a range of new modalities including high intensity focused ultrasound (HIFU).Large numbers of men with localised disease are looking [...]